The US CD38 Monoclonal Antibodies Market is benefiting from substantial investment in multiple myeloma research. Clinical trials and academic research are evaluating CD38-targeted therapies across different disease stages and combination regimens. The CD38 Monoclonal Antibodies Market size is expected to reach US$ 20.63 Billion by 2034 from US$ 8.99 Billion in 2025, registering a CAGR of 9.67%...